Literature DB >> 30174833

Accuracy of rapid on-site evaluation of endobronchial ultrasound guided transbronchial needle aspirates by respiratory registrars in training and medical scientists compared to specialist pathologists-an initial pilot study.

Emily Hopkins1,2, David Moffat3, Caroline Smith3, Michelle Wong1,2, Ian Parkinson4, Walter Nespolon3, Jennifer Buckseall3, Madeline Hill3, Hubertus Jersmann1,2, Phan Nguyen1,2.   

Abstract

BACKGROUND: Rapid on-site evaluation (ROSE) of endobronchial ultrasound guided transbronchial needle aspirates (EBUS-TBNA) increases diagnostic accuracy but in many institutions requires a specialist pathologist. This study aimed to determine if medical scientists or respiratory registrars could adequately perform ROSE to determine sufficiency of EBUS samples.
METHODS: ROSE was performed on the first two EBUS-TBNA passes per patient by a pathologist, a medical scientist and two respiratory registrars. The medical scientists involved had all previously performed ROSE on over 50 procedures. The two respiratory registrars received cytology education from a pathologist in four separate hour-long training sessions. Each ROSE reviewer recorded whether each sample was sufficient or insufficient. Pathologist interpretation was taken as gold standard. Specific diagnosis was not required. Final diagnosis and the total number of passes were also recorded. This study recruited 25 patients (50 passes) for statistical evaluation.
RESULTS: Assessment by specialist pathologists deemed 16/50 (32%) to be sufficient and 34/50 (68%) insufficient respectively. Medical scientists were 90% concordant with the pathologist (K =0.774; 95% CI, 0.587-0.961). The two respiratory registrars were 78% (K =0.568; 95% CI, 0.338-0.798) and 72% (K =0.448; 95% CI, 0.222-0.674) concordant, respectively. The mean number of passes per patient was 4.9 (range, 3-7). A diagnosis was established in 21/25 (82%) patients from the first EBUS-TBNA procedures with the remaining four patients requiring a further procedure or monitoring with serial CT scans to establish the diagnosis. Malignancy was found in 14/25 (56%) patients and a benign process in 11/25 (44%) patients.
CONCLUSIONS: Medical scientist review of ROSE samples is not significantly different to a specialist pathologist and is an acceptable alternative. Respiratory registrars are not a realistic alternative for ROSE without more intensive training, which may be difficult to facilitate in addition to existing respiratory training commitments.

Entities:  

Keywords:  Endobronchial ultrasound (EBUS); bronchoscopy; cytology; rapid on-site evaluation; training

Year:  2018        PMID: 30174833      PMCID: PMC6105983          DOI: 10.21037/jtd.2018.06.61

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  23 in total

1.  Cytotechnologist-attended on-site adequacy evaluation of thyroid fine-needle aspiration: comparison with cytopathologists and correlation with the final interpretation.

Authors:  Matthew T Olson; Armanda D Tatsas; Syed Z Ali
Journal:  Am J Clin Pathol       Date:  2012-07       Impact factor: 2.493

2.  Randomized Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration With and Without Rapid On-site Evaluation for Lung Cancer Genotyping.

Authors:  Rocco Trisolini; Alessandra Cancellieri; Carmine Tinelli; Dario de Biase; Ilaria Valentini; Gianpiero Casadei; Daniela Paioli; Franco Ferrari; Giovanni Gordini; Marco Patelli; Giovanni Tallini
Journal:  Chest       Date:  2015-12       Impact factor: 9.410

3.  On-site adequacy evaluations performed by cytotechnologists: correlation with final interpretations of 5241 image-guided fine-needle aspiration biopsies.

Authors:  Oname O Burlingame; Kessé O Kessé; Stuart G Silverman; Edmund S Cibas
Journal:  Cancer Cytopathol       Date:  2011-08-31       Impact factor: 5.284

4.  Implementation of telecytology for immediate assessment of endoscopic ultrasound-guided fine-needle aspirations compared to conventional on-site evaluation: analysis of 240 consecutive cases.

Authors:  Jonathan D Marotti; Vickie Johncox; David Ng; Jorge L Gonzalez; Vijayalakshmi Padmanabhan
Journal:  Acta Cytol       Date:  2012-09-27       Impact factor: 2.319

5.  Rapid on-site cytologic evaluation during endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing lung cancer: a randomized study.

Authors:  Masahide Oki; Hideo Saka; Chiyoe Kitagawa; Yoshihito Kogure; Naohiko Murata; Takashi Adachi; Masahiko Ando
Journal:  Respiration       Date:  2013-04-03       Impact factor: 3.580

6.  Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

Authors:  M Patricia Rivera; Atul C Mehta
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

7.  Efficacy and cost effectiveness of rapid on site examination (ROSE) in management of patients with mediastinal lymphadenopathies.

Authors:  P Bruno; A Ricci; M C Esposito; D Scozzi; L Tabbì; B Sposato; C Falasca; E Giarnieri; M R Giovagnoli; S Mariotta
Journal:  Eur Rev Med Pharmacol Sci       Date:  2013-06       Impact factor: 3.507

Review 8.  Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis.

Authors:  Ping Gu; Yi-Zhuo Zhao; Li-Yan Jiang; Wei Zhang; Yu Xin; Bao-Hui Han
Journal:  Eur J Cancer       Date:  2009-01-03       Impact factor: 9.162

9.  When Is Rapid On-Site Evaluation Cost-Effective for Fine-Needle Aspiration Biopsy?

Authors:  Robert L Schmidt; Brandon S Walker; Michael B Cohen
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

10.  Experience with multimodality telepathology at the University of Pittsburgh Medical Center.

Authors:  Liron Pantanowitz; Clayton A Wiley; Anthony Demetris; Andrew Lesniak; Ishtiaque Ahmed; William Cable; Lydia Contis; Anil V Parwani
Journal:  J Pathol Inform       Date:  2012-12-20
View more
  1 in total

1.  Efficacy of rapid on-site evaluation for diagnosing pulmonary lesions and mediastinal lymph nodes: a systematic review and meta-analysis.

Authors:  Xi Chen; Bing Wan; Yangyang Xu; Yong Song; Ping Zhan; Litang Huang; Hongbing Liu; Dang Lin; Tangfeng Lv
Journal:  Transl Lung Cancer Res       Date:  2019-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.